This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Knapp M, Windmeijer F, Brown J, Kontodimas S, Tzivelekis S, Haro JM, Ratcliffe M, HONG J, Novick D.Cost-utility analysis of treatment with olanzapine compared with other antipsychotic treatments in patients with schizophrenia in the pan-European SOHO study. PharmacoEconomics 26: 341-358, No. 4, 2008
Rights and permissions
About this article
Cite this article
Olanzapine probably most cost-effective antipsychotic in SOHO. Pharmacoecon. Outcomes News 551, 3 (2008). https://doi.org/10.2165/00151234-200805510-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805510-00005